{"transactions":[{"id":1470029,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-26T00:00:30.000Z","date":"2024-06-25","kind":"exercise","planned":true,"acquired":false,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":62.77,"exercise_date":"2019-02-28","expiration_date":"2028-02-28","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0000950170-24-077522","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077522/ownership.xml","form_type":"4"}},{"id":1470028,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Performance Stock Units","published_at":"2024-06-26T00:00:30.000Z","date":"2024-06-21","kind":"exercise","planned":true,"acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0000950170-24-077522","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077522/ownership.xml","form_type":"4"}},{"id":1470027,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Performance Stock Units","published_at":"2024-06-26T00:00:30.000Z","date":"2024-06-21","kind":"grant","planned":true,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."}],"balance_after":6250,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0000950170-24-077522","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077522/ownership.xml","form_type":"4"}},{"id":1470026,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Performance Stock Units","published_at":"2024-06-26T00:00:30.000Z","date":"2024-06-21","kind":"grant","planned":true,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 7, 2022. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 7, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 7, 2022. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 7, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 7, 2022. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 7, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."}],"balance_after":5500,"derivative":{"underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-24-077522","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077522/ownership.xml","form_type":"4"}},{"id":1470025,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:30.000Z","date":"2024-06-25","kind":"sale","planned":true,"acquired":false,"shares":2549,"price":164.52,"value":419361.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2024."}],"balance_after":17129,"source":{"system":"sec-edgar","filing":"0000950170-24-077522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077522/ownership.xml","form_type":"4"}},{"id":1470024,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:30.000Z","date":"2024-06-25","kind":"sale","planned":true,"acquired":false,"shares":3840,"price":163.53,"value":627955.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.19 to $163.98 inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":19678,"source":{"system":"sec-edgar","filing":"0000950170-24-077522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077522/ownership.xml","form_type":"4"}},{"id":1470023,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:30.000Z","date":"2024-06-25","kind":"sale","planned":true,"acquired":false,"shares":17581,"price":162.65,"value":2859549.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.12 to $163.09, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":23518,"source":{"system":"sec-edgar","filing":"0000950170-24-077522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077522/ownership.xml","form_type":"4"}},{"id":1470022,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:30.000Z","date":"2024-06-25","kind":"sale","planned":true,"acquired":false,"shares":4168,"price":161.82,"value":674465.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.04 to $162.02, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":41099,"source":{"system":"sec-edgar","filing":"0000950170-24-077522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077522/ownership.xml","form_type":"4"}},{"id":1470021,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:30.000Z","date":"2024-06-25","kind":"sale","planned":true,"acquired":false,"shares":975,"price":160.31,"value":156302.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.71 to $160.69, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":45267,"source":{"system":"sec-edgar","filing":"0000950170-24-077522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077522/ownership.xml","form_type":"4"}},{"id":1470020,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:30.000Z","date":"2024-06-25","kind":"sale","planned":true,"acquired":false,"shares":2200,"price":159.14,"value":350108.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.67 to $159.66, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":46242,"source":{"system":"sec-edgar","filing":"0000950170-24-077522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077522/ownership.xml","form_type":"4"}},{"id":1470019,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:30.000Z","date":"2024-06-25","kind":"sale","planned":true,"acquired":false,"shares":7644,"price":158.07,"value":1208287.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.58 to $158.52, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":48442,"source":{"system":"sec-edgar","filing":"0000950170-24-077522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077522/ownership.xml","form_type":"4"}},{"id":1470018,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:30.000Z","date":"2024-06-25","kind":"exercise","planned":true,"acquired":true,"shares":23500,"price":62.77,"value":1475095.0,"ownership":{"direct":true},"balance_after":56086,"source":{"system":"sec-edgar","filing":"0000950170-24-077522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077522/ownership.xml","form_type":"4"}},{"id":1470017,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:30.000Z","date":"2024-06-24","kind":"tax_withholding","planned":true,"acquired":false,"shares":2352,"price":164.64,"value":387233.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 1, 2024."}],"balance_after":32586,"source":{"system":"sec-edgar","filing":"0000950170-24-077522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077522/ownership.xml","form_type":"4"}},{"id":1470016,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:30.000Z","date":"2024-06-21","kind":"exercise","planned":true,"acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."}],"balance_after":34938,"source":{"system":"sec-edgar","filing":"0000950170-24-077522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077522/ownership.xml","form_type":"4"}},{"id":1585300,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-03-12T00:00:13.000Z","date":"2024-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":899,"price":123.14,"value":110702.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022."}],"balance_after":28688,"source":{"system":"sec-edgar","filing":"0000950170-24-029530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024029530/ownership.xml","form_type":"4"}},{"id":1585299,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-03-12T00:00:13.000Z","date":"2024-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":506,"price":120.49,"value":60967.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023."}],"balance_after":29587,"source":{"system":"sec-edgar","filing":"0000950170-24-029530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024029530/ownership.xml","form_type":"4"}},{"id":1592835,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-03-07T01:00:15.000Z","date":"2024-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":1734,"price":125.32,"value":217304.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021."}],"balance_after":30093,"source":{"system":"sec-edgar","filing":"0000950170-24-027495","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024027495/ownership.xml","form_type":"4"}},{"id":1599772,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-06T01:00:12.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter."}],"balance_after":12500,"derivative":{"exercise_price":128.67,"exercise_date":"2025-03-01","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-24-026609","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026609/ownership.xml","form_type":"4"}},{"id":1599771,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-03-06T01:00:12.000Z","date":"2024-03-01","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":125.34,"value":250680.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards."}],"balance_after":31827,"source":{"system":"sec-edgar","filing":"0000950170-24-026609","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026609/ownership.xml","form_type":"4"}},{"id":1599770,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-03-06T01:00:12.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date."}],"balance_after":33827,"source":{"system":"sec-edgar","filing":"0000950170-24-026609","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026609/ownership.xml","form_type":"4"}},{"id":1599769,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2024-03-06T01:00:12.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":269,"price":126.19,"value":33945.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020."}],"balance_after":27827,"source":{"system":"sec-edgar","filing":"0000950170-24-026609","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026609/ownership.xml","form_type":"4"}},{"id":1868230,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2023-06-06T00:00:16.000Z","date":"2023-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":89,"price":123.6,"value":11000.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on May 31, 2019."}],"balance_after":28096,"source":{"system":"sec-edgar","filing":"0001209191-23-034676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123034676/doc4.xml","form_type":"4"}},{"id":1959853,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2023-03-11T01:00:12.000Z","date":"2023-03-08","kind":"tax_withholding","acquired":false,"shares":635,"price":153.19,"value":97275.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022."}],"balance_after":28185,"source":{"system":"sec-edgar","filing":"0001209191-23-018019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123018019/doc4.xml","form_type":"4"}},{"id":1964293,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-09T01:00:47.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter."}],"balance_after":27000,"derivative":{"exercise_price":155.99,"exercise_date":"2024-03-06","expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001209191-23-017400","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017400/doc4.xml","form_type":"4"}},{"id":1964292,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2023-03-09T01:00:47.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date."}],"balance_after":28820,"source":{"system":"sec-edgar","filing":"0001209191-23-017400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017400/doc4.xml","form_type":"4"}},{"id":1964291,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2023-03-09T01:00:47.000Z","date":"2023-03-06","kind":"tax_withholding","acquired":false,"shares":171,"price":157.21,"value":26882.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 4, 2019."}],"balance_after":24320,"source":{"system":"sec-edgar","filing":"0001209191-23-017400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017400/doc4.xml","form_type":"4"}},{"id":1964290,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2023-03-09T01:00:47.000Z","date":"2023-03-06","kind":"tax_withholding","acquired":false,"shares":1154,"price":157.21,"value":181420.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021."}],"balance_after":24491,"source":{"system":"sec-edgar","filing":"0001209191-23-017400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017400/doc4.xml","form_type":"4"}},{"id":1976463,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2023-03-04T01:01:00.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":196,"price":147.57,"value":28923.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on 02/28/2020."}],"balance_after":25645,"source":{"system":"sec-edgar","filing":"0001209191-23-016057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123016057/doc4.xml","form_type":"4"}},{"id":2246081,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-06-04T00:00:15.000Z","date":"2022-06-01","kind":"tax_withholding","acquired":false,"shares":54,"price":72.67,"value":3924.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on May 31, 2019."}],"balance_after":25841,"source":{"system":"sec-edgar","filing":"0001209191-22-034380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122034380/doc4.xml","form_type":"4"}},{"id":2345776,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-09T01:02:13.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter."}],"balance_after":48000,"derivative":{"exercise_price":80.42,"exercise_date":"2023-03-07","expiration_date":"2032-03-07","underlying":"Common Stock","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001209191-22-017346","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122017346/doc4.xml","form_type":"4"}},{"id":2345775,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-03-09T01:02:13.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date."}],"balance_after":25895,"source":{"system":"sec-edgar","filing":"0001209191-22-017346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122017346/doc4.xml","form_type":"4"}},{"id":2345774,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-03-09T01:02:13.000Z","date":"2022-03-07","kind":"tax_withholding","acquired":false,"shares":153,"price":79.36,"value":12142.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 4, 2019."}],"balance_after":17895,"source":{"system":"sec-edgar","filing":"0001209191-22-017346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122017346/doc4.xml","form_type":"4"}},{"id":2345773,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-03-09T01:02:13.000Z","date":"2022-03-04","kind":"tax_withholding","acquired":false,"shares":1136,"price":79.2,"value":89971.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021."}],"balance_after":18048,"source":{"system":"sec-edgar","filing":"0001209191-22-017346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122017346/doc4.xml","form_type":"4"}},{"id":2367047,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-03-02T01:01:45.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":184,"price":75.05,"value":13809.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020."}],"balance_after":19184,"source":{"system":"sec-edgar","filing":"0001209191-22-014407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122014407/doc4.xml","form_type":"4"}},{"id":2684703,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-06-03T20:57:48.000Z","date":"2021-06-01","kind":"tax_withholding","acquired":false,"shares":64,"price":76.01,"value":4864.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on May 31, 2019."}],"balance_after":19368,"source":{"system":"sec-edgar","filing":"0001209191-21-037727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121037727/doc4.xml","form_type":"4"}},{"id":2798049,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-03-11T01:01:55.000Z","date":"2021-03-04","kind":"tax_withholding","acquired":false,"shares":190,"price":80.76,"value":15344.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 4, 2019."}],"balance_after":19432,"source":{"system":"sec-edgar","filing":"0001209191-21-019667","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121019667/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-05"}},{"id":2798048,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-03-11T01:01:55.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 5, 2021, the Form 4 filed for the reporting person overstated the number of shares held by the reporting person. This amended form corrects such error by reporting the number of shares withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units on February 28, 2021 and by reporting the corrected total amount of securities directly owned by the reporting person following a grant of restricted stock units on March 3, 2021."}],"balance_after":19622,"source":{"system":"sec-edgar","filing":"0001209191-21-019667","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121019667/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-05"}},{"id":2798047,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-03-11T01:01:55.000Z","date":"2021-02-28","kind":"tax_withholding","acquired":false,"shares":216,"price":86.97,"value":18785.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 5, 2021, the Form 4 filed for the reporting person overstated the number of shares held by the reporting person. This amended form corrects such error by reporting the number of shares withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units on February 28, 2021 and by reporting the corrected total amount of securities directly owned by the reporting person following a grant of restricted stock units on March 3, 2021."}],"balance_after":4622,"source":{"system":"sec-edgar","filing":"0001209191-21-019667","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121019667/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-05"}},{"id":2807351,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-06T01:02:02.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter."}],"balance_after":60000,"derivative":{"exercise_price":87.11,"exercise_date":"2022-03-03","expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-21-018414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121018414/doc4.xml","form_type":"4"}},{"id":2807350,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":89575,"kind":"person","name":"Brown Ryan Edward","position":1,"cik":"0001848718","reported_name":"Brown Ryan Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-03-06T01:02:02.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest and become exercisable on the first anniversary of the grant date, and additional 25% will vest and become exercisable on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested and exercisable on the fourth anniversary of the grant date."}],"balance_after":19838,"source":{"system":"sec-edgar","filing":"0001209191-21-018414","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121018414/doc4.xml","form_type":"4"}}]}